Privia Health PE Ratio 2020-2024 | PRVA

Current and historical p/e ratio for Privia Health (PRVA) from 2020 to 2024. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Privia Health PE ratio as of May 07, 2025 is 206.54.

Please refer to the Stock Price Adjustment Guide for more information on our historical prices.

Privia Health PE Ratio Historical Data
Date Stock Price TTM Net EPS PE Ratio
2025-05-07 23.32 212.00
2024-12-31 19.55 $0.11 177.73
2024-09-30 18.21 $0.10 182.10
2024-06-30 17.38 $0.12 144.83
2024-03-31 19.59 $0.15 130.60
2023-12-31 23.03 $0.19 121.21
2023-09-30 23.00 $0.31 74.19
2023-06-30 26.11 $0.27 96.70
2023-03-31 27.61 $0.11 251.00
2022-12-31 22.71 $-0.11 0.00
2022-09-30 34.06 $-0.36 0.00
2022-06-30 29.12 $-0.46 0.00
2022-03-31 26.73 $-2.04 0.00
Sector Industry Market Cap Revenue
Medical Medical Information Systems $2.756B $1.736B
Privia Health Group Inc. is a technology-driven, physician enablement company which collaborates with medical groups, health plans and health systems to optimize physician practices, improve patient experiences and reward doctors for delivering high-value care in both in-person and virtual settings. Privia Health Group Inc. is based in Arlington, United States.
Stock Name Country Market Cap PE Ratio
Veeva Systems (VEEV) United States $37.877B 52.32
Hims & Hers Health (HIMS) United States $10.991B 115.05
Tempus AI (TEM) United States $8.988B 0.00
Inspire Medical Systems (INSP) United States $4.774B 74.60
IRhythm Technologies (IRTC) United States $4.316B 0.00
Enovis (ENOV) United States $1.947B 12.05
Schrodinger (SDGR) United States $1.721B 0.00
Clover Health Investments (CLOV) United States $1.712B 0.00
Phreesia (PHR) United States $1.426B 0.00
Omnicell (OMCL) United States $1.202B 21.21
Azenta (AZTA) United States $1.162B 54.08
10x Genomics (TXG) United States $0.991B 0.00
Fulgent Genetics (FLGT) United States $0.573B 0.00
Talkspace (TALK) United States $0.530B 157.25
Butterfly Network (BFLY) United States $0.527B 0.00
Veradigm (MDRX) United States $0.486B 0.00
Standard BioTools (LAB) United States $0.403B 0.00
TruBridge (TBRG) United States $0.381B 0.00
Claritev (CTEV) United States $0.329B 0.00
Health Catalyst (HCAT) United States $0.286B 0.00
Nyxoah SA (NYXH) Belgium $0.218B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.200B 0.00
Pulmonx (LUNG) United States $0.138B 0.00
American Well (AMWL) United States $0.106B 0.00
Retrieve Medical Holdings (RMHI) United States $0.095B 0.00
EUDA Health Holdings (EUDA) Singapore $0.092B 0.00
CareCloud (CCLD) United States $0.091B 3.45
MDxHealth SA (MDXH) Belgium $0.080B 0.00
111 (YI) China $0.069B 0.00
P3 Health Partners (PIII) United States $0.063B 0.00
HeartBeam (BEAT) United States $0.062B 0.00
Outset Medical (OM) United States $0.041B 0.00
Zepp Health (ZEPP) Netherlands $0.040B 0.00
Zhongchao (ZCMD) China $0.033B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.022B 0.00
Bullfrog AI Holdings (BFRG) United States $0.016B 0.00
MSP Recovery (MSPR) United States $0.016B 0.00
Streamline Health Solutions (STRM) United States $0.012B 0.00
Strata Skin Sciences (SSKN) United States $0.011B 0.00
Precipio (PRPO) United States $0.009B 0.00
Predictive Oncology (POAI) United States $0.009B 0.00
Healthcare Triangle (HCTI) United States $0.009B 0.00
Movano (MOVE) United States $0.006B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.004B 0.00
HeartSciences (HSCS) United States $0.004B 0.00
Tivic Health Systems (TIVC) United States $0.003B 0.00
Future Health ESG (FHLT) United States $0.000B 0.00